Annual Accounts Receivable:
$810.73M+$35.64M(+4.60%)Summary
- As of today, RPRX annual accounts receivable is $810.73 million, with the most recent change of +$35.64 million (+4.60%) on December 31, 2024.
- During the last 3 years, RPRX annual accounts receivable has risen by +$128.07 million (+18.76%).
- RPRX annual accounts receivable is now at all-time high.
Performance
RPRX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Accounts Receivable:
$870.68M+$130.34M(+17.60%)Summary
- As of today, RPRX quarterly accounts receivable is $870.68 million, with the most recent change of +$130.34 million (+17.60%) on June 30, 2025.
- Over the past year, RPRX quarterly accounts receivable has increased by +$97.00 million (+12.54%).
- RPRX quarterly accounts receivable is now at all-time high.
Performance
RPRX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
RPRX Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +4.6% | +12.5% |
| 3Y3 Years | +18.8% | +29.1% |
| 5Y5 Years | +65.0% | +54.8% |
RPRX Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +18.8% | at high | +34.3% |
| 5Y | 5-Year | at high | +65.0% | at high | +54.8% |
| All-Time | All-Time | at high | +65.0% | at high | +77.2% |
RPRX Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $870.68M(+17.6%) |
| Mar 2025 | - | $740.34M(-8.7%) |
| Dec 2024 | $810.73M(+4.6%) | $810.73M(+2.5%) |
| Sep 2024 | - | $790.67M(+2.2%) |
| Jun 2024 | - | $773.68M(+13.3%) |
| Mar 2024 | - | $682.71M(-11.9%) |
| Dec 2023 | $775.09M(+6.5%) | $775.09M(-0.6%) |
| Sep 2023 | - | $780.07M(+2.0%) |
| Jun 2023 | - | $765.14M(+18.0%) |
| Mar 2023 | - | $648.46M(-10.9%) |
| Dec 2022 | $727.92M | $727.92M(+2.4%) |
| Sep 2022 | - | $710.70M(+5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $674.59M(+6.0%) |
| Mar 2022 | - | $636.49M(-6.8%) |
| Dec 2021 | $682.66M(+9.0%) | $682.66M(+4.5%) |
| Sep 2021 | - | $653.25M(+1.8%) |
| Jun 2021 | - | $641.69M(+14.1%) |
| Mar 2021 | - | $562.38M(-10.2%) |
| Dec 2020 | $626.36M(+27.5%) | $626.36M(+5.5%) |
| Sep 2020 | - | $593.62M(+5.6%) |
| Jun 2020 | - | $562.39M(+5.8%) |
| Mar 2020 | - | $531.43M(+8.2%) |
| Dec 2019 | $491.33M(-3.7%) | $491.33M |
| Dec 2018 | $510.45M | - |
FAQ
- What is Royalty Pharma plc annual accounts receivable?
- What is the all-time high annual accounts receivable for Royalty Pharma plc?
- What is Royalty Pharma plc annual accounts receivable year-on-year change?
- What is Royalty Pharma plc quarterly accounts receivable?
- What is the all-time high quarterly accounts receivable for Royalty Pharma plc?
- What is Royalty Pharma plc quarterly accounts receivable year-on-year change?
What is Royalty Pharma plc annual accounts receivable?
The current annual accounts receivable of RPRX is $810.73M
What is the all-time high annual accounts receivable for Royalty Pharma plc?
Royalty Pharma plc all-time high annual accounts receivable is $810.73M
What is Royalty Pharma plc annual accounts receivable year-on-year change?
Over the past year, RPRX annual accounts receivable has changed by +$35.64M (+4.60%)
What is Royalty Pharma plc quarterly accounts receivable?
The current quarterly accounts receivable of RPRX is $870.68M
What is the all-time high quarterly accounts receivable for Royalty Pharma plc?
Royalty Pharma plc all-time high quarterly accounts receivable is $870.68M
What is Royalty Pharma plc quarterly accounts receivable year-on-year change?
Over the past year, RPRX quarterly accounts receivable has changed by +$97.00M (+12.54%)